The Formation and Thermal Stability of Polyvinyl Chloride

The thermal stability of Polyvinyl chloride (PVC) was studied. Three phases of degradation were investigated, 1. Dehydrochlorination 2. Discolouration 3. Cross linking The effect of the polymerisation reaction on the final stability of the polymer was also studied, by varying, 1. The type and concentration of initiator 2. The polymerisation temperature 3. The percent polymer conversion 4. The method of polymerisation The polymers thus formed were characterised and then degraded. The results indicate an increase in stability with decrease in polymerisation temperature. The change in initiator type and concentration altered the kinetics of the polymerisation reaction and hence the properties of the polymer formed. Polymers obtained at different conversions exhibited a stability 'Maxima' around 40-60% conversion. Some of the polymers prepared in solution showed marked increase in stability and those prepared by photo irradiation showed a different mechanism of degradation. Two commercial polymers were also studied for comparison. The activation energy for the dehydrochlorination of PVC in solution was found to be 21 k cal/mole and the reaction showed 3 distinct stages. The discolouration, or the polyene formation in PVC due to thermal degradation was characterised into two different reactions with different activation energies. The changes in molecular weight during the degradation is reported. There exists an inverse relationship between the molecular weight of the polymer and the rate of dehydrochlorination

Parâmetros de células vermelhas do pacu Mylossoma duriventre Cuvier, 1817 (Characidae) do lago Coari (AM), Bacia do Médio Rio Solimões (AM).

Resumo simples

Treatment of low strength sewage with high suspended organic matter content in an anaerobic sequencing batch reactor and modeling application

In this work, an anaerobic sequencing batch reactor (ASBR) was operated for 8 months to treat low strength sewage with high suspended organic matter content. Three phases of operation with increasing organic loading rates (OLR) were performed: 0.4 kg COD/m3 x d (phase I), 0 .8 kg COD/m3 x d (phase II) and 1.2 kg COD/m3 x d (phase III). Adequate stability parameters (pH, total alkalinity) were obtained through all three experimental phases. During phases I and II, the removal efficiencies of organic matter (expressed as total chemical oxygen demand (COD) and total suspended solids ranged between 50-60%. However, these values decreased to 15-25% in phase III. In addition, a non-complex model, including hydrolysis, acidogenesis and methanogenesis, was applied to predict the reactor behavior

The nature and fate of natural resins in the geosphere. XII. Investigation of C-ring aromatic diterpenoids in Raritan amber by pyrolysis-GC-matrix isolation FTIR-MS

Upper Cretaceous amber from the Raritan Formation (Sayerville, New Jersey) has been investigated by Pyrolysis-GC-MS and Pyrolysis-GC-matrix isolation FTIR-MS. Results establish the existence of two distinct forms of amber in this deposit. Both forms are Class Ib ambers, but they are unambiguously differentiated on the basis of their (intact) diterpenoid composition. The presence of callitrisate in both forms, and cupraene in samples designated form 1, strongly suggest that both derive from related-but-distinct species within the Cupressaceae. In addition to callitrisate, dehydroabietate and analogous 17-nor-, 16,17-dinor- and 15,16,17-trinor- analogues of these compounds are also observed. The distributions of these products in multiple samples suggest that they are the result of biological emplacement, rather than diagenetic modification of the parent compounds. This indicates that the distributions of diterpenes observed in these samples are representative of the original bioterpenoids and, hence, are useful for chemotaxonomic analyses

Produção de l-asparaginase extracelular por fungos amazônicos

O principal agente terapêutico de doenças hematopoiéticas como a Leucemia Linfoide Aguda (LLA) consiste na aplicação de um biofármaco antileucêmico cujo mecanismo de ação atua na destruição de substâncias indispensáveis ao metabolismo das células tumorais. A L-Asparaginase é uma enzima que opera como agente antineoplásico diminuindo a concentração de asparagina livre no sangue, um aminoácido importante para a sobrevivência de células cancerígenas. A literatura relata que enzimas produzidas por bactérias apresentam reações adversas significativas aos humanos. Nessa direção, a L-Asparaginase de origem fúngica tem mostrado grande potencial no tratamento de LLA, apresentando características similares aquelas produzidas pelo organismo humano. O presente trabalho objetiva avaliar qualitativamente a produção de L-Asparaginase extracelular por fungos filamentosos da Amazônia. Para isso, foram selecionadas dez cepas de fungos filamentosos oriundos de solos e tubérculos amazônicos. O teste foi divido em duas etapas. A primeira etapa pré-fermentativa em meio Czapek Dox (pH 6,2) ideal no cultivo de microrganismos provenientes do solo, no qual permaneceram na incubadora Shaker por 96 horas a 30°C. Na segunda etapa, fermentativa, o micélio filtrado foi reinoculado em um novo meio Czapek Dox acrescido de 0,007% do indicador azul bromotimol, mantido sob agitação constante por 96 horas a 30° C. Os experimentos foram realizados em triplicata e a alteração na cor da solução inoculada para azul representa resultado positivo, visto que o indicador químico induz a mudança de cor à medida que o pH do meio aumenta, resultado da atividade enzimática do microrganismo (liberação da amônia pela hidrólise da L-asparagina). Das cepas fúngicas testadas para a produção extracelular de L-Asparaginase, seis obtiveram resultado positivo, apresentando coloração azul conforme o protocolo. E quatro apresentaram resultado negativo, com coloração não alterada. Por fim, os testes preliminares apontam para as constantes contribuições que a Amazônia oferece na síntese de enzimas para fabricação de biofármacos. Nesse sentido, fica evidente a grande importância em investir nas pesquisas direcionadas ao estudo sobre a capacidade dos fungos filamentosos da região em produzir substâncias de interesse biotecnológico. &nbsp

Absent B Cells, agammaglobulinemia, and Hypertrophic Cardiomyopathy in Folliculin-interacting Protein 1 Deficiency

Agammaglobulinemia is the most profound primary antibody deficiency that can occur due to an early termination of B-cell development. We here investigated 3 novel patients, including the first known adult, from unrelated families with agammaglobulinemia, recurrent infections, and hypertrophic cardiomyopathy (HCM). Two of them also presented with intermittent or severe chronic neutropenia. We identified homozygous or compound-heterozygous variants in the gene for folliculin interacting protein 1 (FNIP1), leading to loss of the FNIP1 protein. B-cell metabolism, including mitochondrial numbers and activity and phosphatidylinositol 3-kinase/AKT pathway, was impaired. These defects recapitulated the Fnip1-/- animal model. Moreover, we identified either uniparental disomy or copy-number variants (CNVs) in 2 patients, expanding the variant spectrum of this novel inborn error of immunity. The results indicate that FNIP1 deficiency can be caused by complex genetic mechanisms and support the clinical utility of exome sequencing and CNV analysis in patients with broad phenotypes, including agammaglobulinemia and HCM. FNIP1 deficiency is a novel inborn error of immunity characterized by early and severe B-cell development defect, agammaglobulinemia, variable neutropenia, and HCM. Our findings elucidate a functional and relevant role of FNIP1 in B-cell development and metabolism and potentially neutrophil activity

A Spaetzle-like role for nerve growth factor beta in vertebrate immunity to Staphylococcus aureus

Many key components of innate immunity to infection are shared between Drosophila and humans. However, the fly Toll ligand Spaetzle is not thought to have a vertebrate equivalent. We have found that the structurally related cystine-knot protein, nerve growth factor β (NGFβ), plays an unexpected Spaetzle-like role in immunity to Staphylococcus aureus infection in chordates. Deleterious mutations of either human NGFβ or its high-affinity receptor tropomyosin-related kinase receptor A (TRKA) were associated with severe S. aureus infections. NGFβ was released by macrophages in response to S. aureus exoproteins through activation of the NOD-like receptors NLRP3 and NLRC4 and enhanced phagocytosis and superoxide-dependent killing, stimulated proinflammatory cytokine production, and promoted calcium-dependent neutrophil recruitment. TrkA knockdown in zebrafish increased susceptibility to S. aureus infection, confirming an evolutionarily conserved role for NGFβ-TRKA signaling in pathogen-specific host immunity

Absent B cells, agammaglobulinemia, and hypertrophic cardiomyopathy in folliculin-interacting protein 1 deficiency

Agammaglobulinemia is the most profound primary antibody deficiency that can occur due to an early termination of B-cell development. We here investigated 3 novel patients, including the first known adult, from unrelated families with agammaglobulinemia, recurrent infections, and hypertrophic cardiomyopathy (HCM). Two of them also presented with intermittent or severe chronic neutropenia. We identified homozygous or compound-heterozygous variants in the gene for folliculin interacting protein 1 (FNIP1), leading to loss of the FNIP1 protein. B-cell metabolism, including mitochondria! numbers and activity and phosphatidylinositol 3-kinase/AKT pathway, was impaired. These defects recapitulated the Fnip1(-/-) animal model. Moreover, we identified either uniparental disomy or copy-number variants (CNVs) in 2 patients, expanding the variant spectrum of this novel inborn error of I immunity. The results indicate that FNIP1 deficiency can be caused by complex genetic mechanisms and support the clinical utility of exome sequencing and CNV analysis in patients with broad phenotypes, including agammaglobulinemia and HCM. FNIP1 deficiency is a novel inborn error of immunity characterized by early and severe B-cell development defect, agammaglobulinemia, variable neutropenia, and HCM. Our findings elucidate a functional and relevant role of FNIP1 in B-cell development and metabolism and potentially neutrophil activity.Molecular Technology and Informatics for Personalised Medicine and Healt

Specific versus Non-Specific Immune Responses in an Invertebrate Species Evidenced by a Comparative de novo Sequencing Study

Our present understanding of the functioning and evolutionary history of invertebrate innate immunity derives mostly from studies on a few model species belonging to ecdysozoa. In particular, the characterization of signaling pathways dedicated to specific responses towards fungi and Gram-positive or Gram-negative bacteria in Drosophila melanogaster challenged our original view of a non-specific immunity in invertebrates. However, much remains to be elucidated from lophotrochozoan species. To investigate the global specificity of the immune response in the fresh-water snail Biomphalaria glabrata, we used massive Illumina sequencing of 5′-end cDNAs to compare expression profiles after challenge by Gram-positive or Gram-negative bacteria or after a yeast challenge. 5′-end cDNA sequencing of the libraries yielded over 12 millions high quality reads. To link these short reads to expressed genes, we prepared a reference transcriptomic database through automatic assembly and annotation of the 758,510 redundant sequences (ESTs, mRNAs) of B. glabrata available in public databases. Computational analysis of Illumina reads followed by multivariate analyses allowed identification of 1685 candidate transcripts differentially expressed after an immune challenge, with a two fold ratio between transcripts showing a challenge-specific expression versus a lower or non-specific differential expression. Differential expression has been validated using quantitative PCR for a subset of randomly selected candidates. Predicted functions of annotated candidates (approx. 700 unisequences) belonged to a large extend to similar functional categories or protein types. This work significantly expands upon previous gene discovery and expression studies on B. glabrata and suggests that responses to various pathogens may involve similar immune processes or signaling pathways but different genes belonging to multigenic families. These results raise the question of the importance of gene duplication and acquisition of paralog functional diversity in the evolution of specific invertebrate immune responses

Rationale, study design, and analysis plan of the Alveolar Recruitment for ARDS Trial (ART): study protocol for a randomized controlled trial

BACKGROUND: Acute respiratory distress syndrome (ARDS) is associated with high in-hospital mortality. Alveolar recruitment followed by ventilation at optimal titrated PEEP may reduce ventilator-induced lung injury and improve oxygenation in patients with ARDS, but the effects on mortality and other clinical outcomes remain unknown. This article reports the rationale, study design, and analysis plan of the Alveolar Recruitment for ARDS Trial (ART). METHODS/DESIGN: ART is a pragmatic, multicenter, randomized (concealed), controlled trial, which aims to determine if maximum stepwise alveolar recruitment associated with PEEP titration is able to increase 28-day survival in patients with ARDS compared to conventional treatment (ARDSNet strategy). We will enroll adult patients with ARDS of less than 72 h duration. The intervention group will receive an alveolar recruitment maneuver, with stepwise increases of PEEP achieving 45 cmH2O and peak pressure of 60 cmH2O, followed by ventilation with optimal PEEP titrated according to the static compliance of the respiratory system. In the control group, mechanical ventilation will follow a conventional protocol (ARDSNet). In both groups, we will use controlled volume mode with low tidal volumes (4 to 6 mL/kg of predicted body weight) and targeting plateau pressure 6430 cmH2O. The primary outcome is 28-day survival, and the secondary outcomes are: length of ICU stay; length of hospital stay; pneumothorax requiring chest tube during first 7 days; barotrauma during first 7 days; mechanical ventilation-free days from days 1 to 28; ICU, in-hospital, and 6-month survival. ART is an event-guided trial planned to last until 520 events (deaths within 28 days) are observed. These events allow detection of a hazard ratio of 0.75, with 90% power and two-tailed type I error of 5%. All analysis will follow the intention-to-treat principle. DISCUSSION: If the ART strategy with maximum recruitment and PEEP titration improves 28-day survival, this will represent a notable advance to the care of ARDS patients. Conversely, if the ART strategy is similar or inferior to the current evidence-based strategy (ARDSNet), this should also change current practice as many institutions routinely employ recruitment maneuvers and set PEEP levels according to some titration metho